Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1

Interventions

Peripheral Blood Stem Cell Transplantation 42fludarabine phosphate 37Cyclophosphamide 36Mycophenolic Acid 28Whole-Body Irradiation 26Cyclosporine 25Busulfan 25Tacrolimus 22Antilymphocyte Serum 21Methotrexate 16Filgrastim 16Etoposide 15Methylprednisolone 13Melphalan 13Radiotherapy 12Flow Cytometry 11Psychiatric Rehabilitation 10Therapeutics 9Rituximab 9Polymerase Chain Reaction 8Bortezomib 8Gemcitabine 7Cord Blood Stem Cell Transplantation 7sargramostim 6Vorinostat 6Sirolimus 6tanespimycin 5Transplantation 5Thiotepa 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × navitoclax × Dermatologic × Clear all
NCT00406809 2021-08-02

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

AbbVie

Phase 1/2 Completed
81 enrolled
DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Leukemia, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡